Your browser doesn't support javascript.
loading
Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma.
Kang, Nan; Zhang, Yinli; Guo, Shichao; Chen, Ran; Kong, Fangzhou; Wang, Shuchun; Yuan, Mingming; Chen, Rongrong; Shen, Danhua; Wang, Jianliu.
Afiliación
  • Kang N; Department of Pathology, Peking University People's Hospital, Beijing, China.
  • Zhang Y; Department of Pathology, Peking University People's Hospital, Beijing, China.
  • Guo S; State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Chen R; Department of Pathology, Peking University People's Hospital, Beijing, China.
  • Kong F; Department of Pathology, Peking University People's Hospital, Beijing, China.
  • Wang S; Geneplus-Beijing, Beijing, China.
  • Yuan M; Geneplus-Beijing, Beijing, China.
  • Chen R; Geneplus-Beijing, Beijing, China.
  • Shen D; Department of Pathology, Peking University People's Hospital, Beijing, China.
  • Wang J; Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
Cancer Res Treat ; 55(3): 978-991, 2023 Jul.
Article en En | MEDLINE | ID: mdl-36731460

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Sarcoma Estromático Endometrial Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Endometriales / Sarcoma Estromático Endometrial Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: Cancer Res Treat Año: 2023 Tipo del documento: Article País de afiliación: China
...